Aethlon Retained Earnings Total Equity from 2010 to 2024

AEMD Stock  USD 0.58  0.15  34.88%   
Aethlon Medical's Retained Earnings Total Equity is decreasing over the years with slightly volatile fluctuation. Retained Earnings Total Equity is expected to dwindle to about -113.3 M. Retained Earnings Total Equity is the portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt. View All Fundamentals
 
Retained Earnings Total Equity  
First Reported
2011-06-30
Previous Quarter
-119.9 M
Current Value
-122 M
Quarterly Volatility
21.3 M
 
Yuan Drop
 
Covid
Check Aethlon Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aethlon Medical's main balance sheet or income statement drivers, such as Interest Expense of 158.4 M, Other Operating Expenses of 13.3 M or Total Operating Expenses of 12.9 M, as well as many indicators such as Price To Sales Ratio of 14.85, Dividend Yield of 0.0 or PTB Ratio of 0.79. Aethlon financial statements analysis is a perfect complement when working with Aethlon Medical Valuation or Volatility modules.
  
Check out the analysis of Aethlon Medical Correlation against competitors.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.

Latest Aethlon Medical's Retained Earnings Total Equity Growth Pattern

Below is the plot of the Retained Earnings Total Equity of Aethlon Medical over the last few years. It is the portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt. Aethlon Medical's Retained Earnings Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aethlon Medical's overall financial position and show how it may be relating to other accounts over time.
Retained Earnings Total Equity10 Years Trend
Slightly volatile
   Retained Earnings Total Equity   
-93.8M-99.5M-105.7M-112.0M-119.9M-107.9M-113.3M100%
       Timeline  

Aethlon Retained Earnings Total Equity Regression Statistics

Arithmetic Mean(94,291,476)
Coefficient Of Variation(24.40)
Mean Deviation19,171,152
Median(99,457,714)
Standard Deviation23,003,815
Sample Variance529.2T
Range63.3M
R-Value(0.93)
Mean Square Error76T
R-Squared0.87
Slope(4,788,715)
Total Sum of Squares7408.5T

Aethlon Retained Earnings Total Equity History

2024-113.3 M
2023-107.9 M
2020-119.9 M
2019-112 M
2018-105.7 M
2017-99.5 M
2016-93.8 M

About Aethlon Medical Financial Statements

Aethlon Medical stakeholders use historical fundamental indicators, such as Aethlon Medical's Retained Earnings Total Equity, to determine how well the company is positioned to perform in the future. Although Aethlon Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aethlon Medical's assets and liabilities are reflected in the revenues and expenses on Aethlon Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aethlon Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Retained Earnings Total Equity-107.9 M-113.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:
Check out the analysis of Aethlon Medical Correlation against competitors.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.79)
Revenue Per Share
0.236
Quarterly Revenue Growth
42.782
Return On Assets
(0.50)
Return On Equity
(1.05)
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Trending Assets

RPID
Rapid Micro Biosystems
0.90  -0.1  -10 
OSA
ProSomnus, Common Stock
0.47  0.00  0.00 
DCTH
Delcath Systems
11.01  -0.17  -1.52 
HSCS
Heart Test Laboratories
3.83  0.41  11.99 
News Freq…Investor S…